ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000269737.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.043739666	Resistant
ENSG00000269737.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.01737216	Resistant